Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
0.00% $30.80
America/New_York / 2 mai 2024 @ 10:04
FUNDAMENTALS | |
---|---|
MarketCap: | 10 181 mill |
EPS: | 2.01 |
P/E: | 15.32 |
Earnings Date: | Jul 24, 2024 |
SharesOutstanding: | 330.56 mill |
Avg Daily Volume: | 0.0017 mill |
RATING 2024-05-02 |
---|
A |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Buy | |
DE: | Neutral | |
P/E: | Neutral | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/21 | 4/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.53x |
Company: PE 15.32 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.49x |
Company: PE 15.32 | industry: PE 31.46 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 30.21 - 31.39 ( +/- 1.90%) |
ATR Model: 14 days |